Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
105 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)
In this report, the EMEA Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Biosimilars for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Biosimilars market competition by top manufacturers/players, with Biosimilars sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Sandoz International GmbH
Teva Pharmaceuticals Industries
Amgen Inc
Biocon
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
Celltrion
Samsung Bioepis
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Oncology
Blood Disorders
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Biosimilars Market Report 2017
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
1.2.1 EMEA Biosimilars Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.5 Peptides (Glucagon, Calcitonin)
1.3 EMEA Biosimilars Market by Application/End Users
1.3.1 EMEA Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 EMEA Biosimilars Market by Region
1.4.1 EMEA Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biosimilars (2012-2022)
1.5.1 EMEA Biosimilars Sales and Growth Rate (2012-2022)
1.5.2 EMEA Biosimilars Revenue and Growth Rate (2012-2022)
2 EMEA Biosimilars Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Biosimilars Market Competition by Players/Manufacturers
2.1.1 EMEA Biosimilars Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Biosimilars Revenue and Share by Players (2012-2017)
2.1.3 EMEA Biosimilars Sale Price by Players (2012-2017)
2.2 EMEA Biosimilars (Volume and Value) by Type/Product Category
2.2.1 EMEA Biosimilars Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Biosimilars Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Biosimilars Sale Price by Type (2012-2017)
2.3 EMEA Biosimilars (Volume) by Application
2.4 EMEA Biosimilars (Volume and Value) by Region
2.4.1 EMEA Biosimilars Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Biosimilars Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Biosimilars Sales Price by Region (2012-2017)
3 Europe Biosimilars (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Biosimilars Sales and Value (2012-2017)
3.1.1 Europe Biosimilars Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Biosimilars Revenue and Growth Rate (2012-2017)
3.2 Europe Biosimilars Sales and Market Share by Type
3.3 Europe Biosimilars Sales and Market Share by Application
3.4 Europe Biosimilars Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Biosimilars Sales Volume by Countries (2012-2017)
3.4.2 Europe Biosimilars Revenue by Countries (2012-2017)
3.4.3 Germany Biosimilars Sales and Growth Rate (2012-2017)
3.4.4 France Biosimilars Sales and Growth Rate (2012-2017)
3.4.5 UK Biosimilars Sales and Growth Rate (2012-2017)
3.4.6 Russia Biosimilars Sales and Growth Rate (2012-2017)
3.4.7 Italy Biosimilars Sales and Growth Rate (2012-2017)
3.4.8 Benelux Biosimilars Sales and Growth Rate (2012-2017)
4 Middle East Biosimilars (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Biosimilars Sales and Value (2012-2017)
4.1.1 Middle East Biosimilars Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Biosimilars Revenue and Growth Rate (2012-2017)
4.2 Middle East Biosimilars Sales and Market Share by Type
4.3 Middle East Biosimilars Sales and Market Share by Application
4.4 Middle East Biosimilars Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Biosimilars Sales Volume by Countries (2012-2017)
4.4.2 Middle East Biosimilars Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Biosimilars Sales and Growth Rate (2012-2017)
4.4.4 Israel Biosimilars Sales and Growth Rate (2012-2017)
4.4.5 UAE Biosimilars Sales and Growth Rate (2012-2017)
4.4.6 Iran Biosimilars Sales and Growth Rate (2012-2017)
5 Africa Biosimilars (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Biosimilars Sales and Value (2012-2017)
5.1.1 Africa Biosimilars Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Biosimilars Revenue and Growth Rate (2012-2017)
5.2 Africa Biosimilars Sales and Market Share by Type
5.3 Africa Biosimilars Sales and Market Share by Application
5.4 Africa Biosimilars Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Biosimilars Sales Volume by Countries (2012-2017)
5.4.2 Africa Biosimilars Revenue by Countries (2012-2017)
5.4.3 South Africa Biosimilars Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Biosimilars Sales and Growth Rate (2012-2017)
5.4.5 Egypt Biosimilars Sales and Growth Rate (2012-2017)
5.4.6 Algeria Biosimilars Sales and Growth Rate (2012-2017)
6 EMEA Biosimilars Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biosimilars Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sandoz International GmbH
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Biosimilars Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sandoz International GmbH Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva Pharmaceuticals Industries
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Biosimilars Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Pharmaceuticals Industries Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Amgen Inc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Biosimilars Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Amgen Inc Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biocon
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Biosimilars Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Dr. Reddy's Laboratories
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Biosimilars Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 F. Hoffmann-La Roche
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Biosimilars Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 F. Hoffmann-La Roche Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Celltrion
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Biosimilars Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Samsung Bioepis
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Biosimilars Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Samsung Bioepis Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
7 Biosimilars Manufacturing Cost Analysis
7.1 Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilars
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Biosimilars Market Forecast (2017-2022)
11.1 EMEA Biosimilars Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Biosimilars Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Biosimilars Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Biosimilars Price and Trend Forecast (2017-2022)
11.2 EMEA Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biosimilars Sales Forecast by Type (2017-2022)
11.7 EMEA Biosimilars Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Biosimilars
Figure EMEA Biosimilars Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure Peptides (Glucagon, Calcitonin) Product Picture
Figure EMEA Biosimilars Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Biosimilars by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Blood Disorders Examples
Table Key Downstream Customer in Blood Disorders
Figure EMEA Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure Europe Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biosimilars Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biosimilars Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Biosimilars Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Biosimilars Sales Share by Players (2012-2017)
Figure 2016 Biosimilars Sales Share by Players
Figure 2017 Biosimilars Sales Share by Players
Figure EMEA Biosimilars Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biosimilars Revenue (Million USD) by Players (2012-2017)
Table EMEA Biosimilars Revenue Share by Players (2012-2017)
Table 2016 EMEA Biosimilars Revenue Share by Players
Table 2017 EMEA Biosimilars Revenue Share by Players
Table EMEA Biosimilars Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Biosimilars Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilars by Type (2012-2017)
Figure EMEA Biosimilars Sales Market Share by Type (2012-2017)
Table EMEA Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilars by Type in 2016
Table EMEA Biosimilars Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Biosimilars Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilars by Application (2012-2017)
Figure EMEA Biosimilars Sales Market Share by Application in 2016
Table EMEA Biosimilars Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilars by Region (2012-2017)
Figure EMEA Biosimilars Sales Market Share in 2016
Table EMEA Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biosimilars Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biosimilars by Region (2012-2017)
Figure EMEA Biosimilars Revenue Market Share Regions in 2016
Table EMEA Biosimilars Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Biosimilars Revenue and Growth Rate (2012-2017)
Table Europe Biosimilars Sales (K MT) by Type (2012-2017)
Table Europe Biosimilars Market Share by Type (2012-2017)
Figure Europe Biosimilars Market Share by Type in 2016
Table Europe Biosimilars Sales (K MT) by Application (2012-2017)
Table Europe Biosimilars Market Share by Application (2012-2017)
Figure Europe Biosimilars Market Share by Application in 2016
Table Europe Biosimilars Sales (K MT) by Countries (2012-2017)
Table Europe Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilars Sales Market Share by Countries in 2016
Table Europe Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Europe Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilars Revenue Market Share by Countries in 2016
Figure Germany Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure France Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure UK Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biosimilars Sales (K MT) by Type (2012-2017)
Table Middle East Biosimilars Market Share by Type (2012-2017)
Figure Middle East Biosimilars Market Share by Type (2012-2017)
Table Middle East Biosimilars Sales (K MT) by Applications (2012-2017)
Table Middle East Biosimilars Market Share by Applications (2012-2017)
Figure Middle East Biosimilars Sales Market Share by Application in 2016
Table Middle East Biosimilars Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Biosimilars Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biosimilars Sales Volume Market Share by Countries in 2016
Table Middle East Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilars Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biosimilars Sales (K MT) by Type (2012-2017)
Table Africa Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa Biosimilars Sales Market Share by Type in 2016
Table Africa Biosimilars Sales (K MT) by Application (2012-2017)
Table Africa Biosimilars Sales Market Share by Application (2012-2017)
Figure Africa Biosimilars Sales Market Share by Application (2012-2017)
Table Africa Biosimilars Sales Volume (K MT) by Countries (2012-2017)
Table Africa Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilars Sales Market Share by Countries in 2016
Table Africa Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Africa Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilars Revenue Market Share by Countries in 2016
Figure South Africa Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Table Pfizer Biosimilars Basic Information List
Table Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Sandoz International GmbH Biosimilars Basic Information List
Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sandoz International GmbH Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Sandoz International GmbH Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Sandoz International GmbH Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceuticals Industries Biosimilars Basic Information List
Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceuticals Industries Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Amgen Inc Biosimilars Basic Information List
Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Inc Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Amgen Inc Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Biocon Biosimilars Basic Information List
Table Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocon Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Biocon Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Biocon Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddy's Laboratories Biosimilars Basic Information List
Table Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Dr. Reddy's Laboratories Biosimilars Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Biosimilars Basic Information List
Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Biosimilars Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Celltrion Biosimilars Basic Information List
Table Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celltrion Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Celltrion Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Celltrion Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Samsung Bioepis Biosimilars Basic Information List
Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Samsung Bioepis Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Samsung Bioepis Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Samsung Bioepis Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2016
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure EMEA Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilars Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Biosimilars Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Biosimilars Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biosimilars Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biosimilars Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biosimilars Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Biosimilars Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biosimilars Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
